These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5310119)

  • 21. [Treatment of atherosclerosis by pyridinolcarbamate. Review of the history of the introduction of pyridinolcarbamate and its clinical results].
    Shimamoto T
    Rev Atheroscler (Paris); 1968; 10(3):67-84. PubMed ID: 5746502
    [No Abstract]   [Full Text] [Related]  

  • 22. [New drugs registered in Austria].
    Wien Klin Wochenschr; 1972 Mar; 84(12):200-1. PubMed ID: 5012428
    [No Abstract]   [Full Text] [Related]  

  • 23. [Use of clofibrate and pyridinol carbamate singly or in combination in the antiarteriosclerotic therapy].
    Meciani L; Boeri S; Ricci G
    Minerva Cardioangiol; 1974; 22(7-8):512-42. PubMed ID: 4606052
    [No Abstract]   [Full Text] [Related]  

  • 24. [Synthetic studies on antiatherogenic agents (II) syntheses of carbamate derivative of phthalazinones (author's transl)].
    Ishikawa M; Egughi Y; Sugimoto A
    Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1975; 9():145-68. PubMed ID: 1076757
    [No Abstract]   [Full Text] [Related]  

  • 25. [Synthetic studies on antiatherogenic agents (III) syntheses of carbamate derivative of quinazolinones (author's transl)].
    Ishikawa M; Egughi Y; Kaneshiro S
    Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1975; 9():169-81. PubMed ID: 1076758
    [No Abstract]   [Full Text] [Related]  

  • 26. [Synthetic studies on antiatherogenic agents (I). Syntheses of carbamate derivatives of diazines (author's transl)].
    Ishikawa M; Eguchi Y
    Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1974; 8():9-20. PubMed ID: 4534365
    [No Abstract]   [Full Text] [Related]  

  • 27. [Fibrinolytic factors in atherosclerosis].
    Coccheri S
    Bull Sci Med (Bologna); 1967; 139(4):474-80. PubMed ID: 4236949
    [No Abstract]   [Full Text] [Related]  

  • 28. [Laboratory investigations on the effect of a heparinoid].
    Harmanci N; Akman N; Ulutin ON
    Rev Med Moyen Orient; 1965; 22(6):541-5. PubMed ID: 5217700
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical and laboratory examinations with Prodectin.
    Bédi J; Kosztovics A; Pálos LA
    Ther Hung; 1976; 24(3):91-7. PubMed ID: 1013926
    [No Abstract]   [Full Text] [Related]  

  • 30. The effects of piridinol carbamate on hypercholesteremia and aortal damage produced by 5 days' application of Altman's diet to the rat.
    Iwanowska J; Starzyński S; Kalinowska A
    Pol J Pharmacol Pharm; 1980; 32(3):333-41. PubMed ID: 6974352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Complex therapy of arteriosclerosis of the lower limbs].
    Bocharov AA; Kohhan EP
    Khirurgiia (Mosk); 1971 Dec; 47(12):37-9. PubMed ID: 5141186
    [No Abstract]   [Full Text] [Related]  

  • 32. [Electrocardiographic and rheographic modifications in arteriosclerotics treated with polysulfoester of pentosan (SP-54)].
    Aguglia V; Sgroi C; Cerasola GA
    Boll Soc Ital Cardiol; 1972; 17(2):65-75. PubMed ID: 5071185
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pyridinolcarbamate in the therapy of hemicrania syndromes].
    Spina A
    Acta Neurol (Napoli); 1972; 27(6):610-7. PubMed ID: 4651488
    [No Abstract]   [Full Text] [Related]  

  • 34. Bradykinin as a causative agent in hemorrhage and its prevention by antibradykinin substances.
    Shimamoto T; Kubota A; Ishioka T
    Nihon Ketsueki Gakkai Zasshi; 1968 Jun; 31(3):350-62. PubMed ID: 5751949
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pathogenetic treatment of patients with disseminated neurodermatitis using the specific antikinin preparation parmidin].
    Grebennikov VA
    Sov Med; 1983; (1):44-7. PubMed ID: 6836389
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical and plethysmographic evaluation in patients with peripheral arteriopathies treated with pyridinolcarbamate].
    Lucero Eseverri JA; Fajardo JD; Velles Aguirre L; Quijano E; Ciliberti E; Lucarelli R
    Prensa Med Argent; 1970 Apr; 57(8):394-8. PubMed ID: 5517707
    [No Abstract]   [Full Text] [Related]  

  • 37. Antiatherogenic effect of pyridinolcarbamate (prodectin). Experimental study.
    Orbetzova V; Jurukova Z; Orbetzova M
    Artery; 1980; 8(6):560-9. PubMed ID: 7259535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of atherosclerosis].
    Villaverde MM; Sadow HS
    Rev Clin Esp; 1967 Jan; 104(1):67-73. PubMed ID: 5596051
    [No Abstract]   [Full Text] [Related]  

  • 39. Progression of occlusive atherosclerosis. Long-term administration of pyridinol carbamate.
    Redisch W; Clauss RH; Rouen LR; Katz MC; Terry EN
    Arch Surg; 1975 Mar; 110(3):258-61. PubMed ID: 803830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical results of the application of n-methyl-carbamate in alveolar blennorrhea].
    Nishida Y; Chiba E; Kawashima Y; Kato K; Furumi K
    Shikwa Gakuho; 1968 Jul; 68(7):1071-7. PubMed ID: 5247161
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.